NGM Biopharmaceuticals Inc (NASDAQ:NGM)

5.40
Delayed Data
As of 3:59pm ET
 +0.19 / +3.65%
Today’s Change
2.92
Today|||52-Week Range
19.14
-69.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues85.6M77.1M108.7M--
 
 
 
 
Depreciation And Amortization3.5M6.4M7.2M--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses90.4M88.1M105.8M--
 
 
 
 
Research And Development82.1M79.7M95.7M--
 
 
 
 
Total Operating Expenses94.0M94.6M113.0M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.4M-17.4M-4.3M--
 
 
 
 
Extraordinary Credit0.000.0077.0K--
 
 
Other Expenses133.0K-152.0K122.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.4M-15.2M-493.0K--
 
 
 
 
Income Taxes-500.0K-1.1M0.00--
 
 
 
Net Income-6.9M-14.2M-493.0K--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.1M11.9M66.0M--
 
 
 
 
Shares To Calculate EPS Diluted11.1M11.9M66.0M--
 
 
 
 
 
Earnings Per ShareEPS-$0.63-$1.19-$0.01--
 
 
 
 
EPS Diluted-$0.63-$1.19-$0.01--